MaaT Pharma SA announced the appointment of Jonathan Chriqui, PharmD, as Chief Business Officer and member of the executive management team. Jonathan Chriqui will be responsible for MaaT Pharma?s business development and partnering strategies along with promoting MaaT Pharma's innovations within the microbiome industry. Jonathan brings over 15 years of business development experience working at Ipsen and Servier, including leadership in strategic transactions in the field of microbiota as well as collaborations, licensing, M&A, and alliance management.

Previously, he held the role of Chief Operating & Chief Business Development Officer at Somagenetix in Zurich, Switzerland, which is developing gene therapies for rare diseases in immunology, neurology, and oncology.